Particle.news
Download on the App Store

IMPI Recognizes UMSNH’s Patent Output Under Plan Michoacán

The visit advanced a strategy to turn protected inventions into economic gains through technology transfer.

Overview

  • IMPI director Santiago Nieto visited UMSNH in Morelia to deliver patent title recognitions, with reports differing on whether seven or twelve were presented.
  • Nieto affirmed that UMSNH is the leading patent-generating institution in Michoacán.
  • Recognized inventions span biomedicine, agriculture and biotechnology, including anti-inflammatory compounds, anti-obesity cyclodipeptides, plant‑growth–promoting Pseudomonas strains and an antifungal capsaicinoid, with one title involving Applied Biotec.
  • IMPI highlighted national metrics, citing a record 700 Mexican patents in 2024 and 877 by late 2025, noting Michoacán ranks ninth in applications and a pronounced gender gap in filings.
  • Separately, the redesigned 2025 Innovation Prize drew 3,763 submissions, a 4,917% increase after opening the call to broader ideas and early‑stage projects.